Goodwill Pharma Plc Logo

Goodwill Pharma Plc

Integrated pharma CDMO developing Rx/OTC meds, supplements & devices for CEE markets.

GWPH | BUD

Overview

Corporate Details

ISIN(s):
HU0000199575
LEI:
Country:
Hungary
Address:
N/A
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Goodwill Pharma Plc is a fully integrated pharmaceutical company specializing in the development, manufacturing, and distribution of therapeutic products. Its portfolio includes prescription (Rx) and over-the-counter (OTC) medications, food supplements, and medical devices. Primarily serving the Central and Eastern European (CEE) markets, the company is expanding its international presence through strategic partnerships and exports. As a full-service Contract Development and Manufacturing Organization (CDMO), Goodwill Pharma provides comprehensive solutions across the entire product lifecycle, from research and development in collaboration with academic institutions to large-scale commercial manufacturing, regulatory affairs, logistics, and marketing support. The company focuses on making high-quality, innovative, and accessible healthcare products available to patients and healthcare professionals.

This is a Fraction of the Available Data.

You're viewing a limited, static snapshot. Professionals use our API to get real-time, AI-ready data for Goodwill Pharma Plc and 9,000+ other companies.

Stop analyzing yesterday's news. Start building a real-time advantage.

Request Enterprise API Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-09-01 10:57
Regulatory News Service
Tájékoztatás alaptőkéről és szavazati jogokról
Hungarian 153.3 KB
2025-08-25 10:06
Notice of Dividend Amount
Osztalékfizetés
Hungarian 137.4 KB
2025-08-01 09:49
Share Issue/Capital Change
Tájékoztatás alaptőkéről és szavazati jogokról
Hungarian 153.4 KB
2025-07-21 13:20
Notice of Dividend Amount
Osztalékfizetés
Hungarian 136.6 KB

Automate Your Workflow. Get a real-time feed of all Goodwill Pharma Plc filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Goodwill Pharma Plc via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
SanBio Company Limited Logo
Developing regenerative cell therapies for severe neurological disorders like brain injury and stroke.
Japan 4592
Sanofi Logo
Global biopharma firm researching, developing & marketing prescription medicines & vaccines.
France SAN
SANTEN PHARMACEUTICAL CO.,LTD. Logo
A global ophthalmology specialist developing drugs and devices for glaucoma, dry eye, and infections.
Japan 4536
Santhera Pharmaceuticals Holding AG Logo
Develops innovative medicines for rare neuromuscular and mitochondrial disorders.
Switzerland SANN
SAWAI GROUP HOLDINGS Co., Ltd. Logo
A leading Japanese generic drug maker expanding into digital health and wellness solutions.
Japan 4887
Scandion Oncology A/S Logo
Biotech company in liquidation, formerly developing therapies to overcome cancer drug resistance.
Denmark SCOL
Seach Medical Group Ltd. Logo
Researches, cultivates, and produces certified medical cannabis oils and flowers for global markets.
Israel SEMG
SEIKAGAKU CORPORATION Logo
A research pharma company using glycoscience to develop drugs for orthopedic & ophthalmic diseases.
Japan 4548
SEYİTLER KİMYA SANAYİ A.Ş. Logo
Manufacturer of medical tapes, wound dressings, and first aid plasters for the healthcare industry.
Türkiye SEYKM
Shedir Pharma Group Logo
Develops and sells pharmaceutical, nutraceutical, and dermo-cosmetic products in Italy & Spain.
Italy SHE

Talk to a Data Expert

Have a question? We'll get back to you promptly.